Successful treatment of corticosteroid-resistant ophiasis-type alopecia areata (AA) with platelet-rich plasma (PRP)

JAAD Case Reports

Volumn 1, Issue 5, 2015, Pages 305-307

  Donovan, Jeff ^a  

^a UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENALIN; LIDOCAINE; MINOXIDIL; PARACETAMOL; STEROID; TRIAMCINOLONE ACETONIDE;

ADULT; ALOPECIA AREATA; ARTICLE; BIPOLAR DISORDER; CASE REPORT; CORTICOSTEROID THERAPY; DRUG TREATMENT FAILURE; ERYTHEMA; FEMALE; HAIR GROWTH; HAIR LOSS; HUMAN; INJECTION SITE BLEEDING; INJECTION SITE BURNING; INJECTION SITE PAIN; INJECTION SITE REACTION; LOCAL ANESTHESIA; MOOD CHANGE; NERVE INJURY; OPHIASIS TYPE ALOPECIA AREATA; PRIORITY JOURNAL; STEROID THERAPY; SWELLING; THROMBOCYTE COUNT; THROMBOCYTE POOR PLASMA;

EID: 84939610465     PISSN: None     EISSN: 23525126     Source Type: Journal    
DOI: 10.1016/j.jdcr.2015.07.004     Document Type: Article

References (10)

1. Hordinksy M.K. Overview of alopecia areata. J Investig Dermatol Symp Proc 2013, 16:S13-S15.
2. Shapiro J. Current treatment of alopecia areata. J Investig Dermatol Symp Proc 2013, 16:S42-S44.
3. Takikawa M., Nakamura S., Nakamura A., et al. Enhanced effect of platelet rich plasma containing a new carrier on hair growth. Dermatol Surg 2011, 37:1721-1729.
4. Li Z.J., Choi H.I., Choi D.K., et al. Autologous platelet-rich plasma: a potential therapeutic tool for promoting hair growth. Dermatol Surg 2012, 38:1040-1046.
5. Trink A., Sorbellini E., Bezzola P., et al. A randomized, double-blind, placebo- and active-controlled, half-head study to evaluate the effects of platelet rich plasma on alopecia areata. Br J Dermatol 2013, 169:690-694.
6. Fishman S.M., Catarau E.M., Sachs G., Stojanovic M., Borsook D. Corticosteroid-induced mania after a single regional application at the celiac plexus. Anesthesiology 1996, 85:1194-1196.
7. Naber D., Sand P., Heigl B. Psychopathological and neuropsychological effects of 8-days' corticosteroid treatment: a prospective study. Psychoneuroendocrinology 1996, 21:25-31.
8. Acute adverse reactions to prednisone in relation to dosage. Clin Pharmacol Ther 1972, 13:694-698. The Boston Collaborative Drug Surveillance Program.
9. Colon E.A., Popkin M.K., Callies A.L., Dessert N.J., Hordinsky M.K. Lifetime prevalence of psychiatric disorders in patients with alopecia areata. Compr Psychiatry 1991, 32:2245-2251.
10. Koo J.Y., Shellow W.V., Hallman C.P., Edwards J.E. Alopecia areata and increased prevalence of psychiatric disorders. Int J Dermatol 1994, 33:849-850.